Daniel Ceballos

766 total citations
22 papers, 204 citations indexed

About

Daniel Ceballos is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Daniel Ceballos has authored 22 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Genetics and 12 papers in Surgery. Recurrent topics in Daniel Ceballos's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (13 papers) and Eosinophilic Esophagitis (4 papers). Daniel Ceballos is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (13 papers) and Eosinophilic Esophagitis (4 papers). Daniel Ceballos collaborates with scholars based in Spain, Austria and Netherlands. Daniel Ceballos's co-authors include M.À. Gassull, Cristina Morales Saro, José Luis Cabriada, Fernando Gomollón, Guillermo Bastida, Joaquín Hinojosa, M. Peñate, Alejandro Hernández-Camba, Laura Ramos and Norberto Santana-Rodríguez and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Journal of Pain and Symptom Management.

In The Last Decade

Daniel Ceballos

19 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ceballos Spain	7	130	95	76	31	22	22	204
Cécile Poupardin France	8	111 0.9×	96 1.0×	77 1.0×	4 0.1×	39 1.8×	12	243
Maureen McCauley United States	4	90 0.7×	66 0.7×	72 0.9×	35 1.1×	10 0.5×	6	249
Tanja Sofie Hansen Denmark	5	220 1.7×	171 1.8×	174 2.3×	24 0.8×	12 0.5×	6	409
Beata Klincewicz Poland	7	68 0.5×	50 0.5×	54 0.7×	3 0.1×	22 1.0×	9	206
J. Masure United States	4	223 1.7×	204 2.1×	80 1.1×	30 1.0×	6 0.3×	5	298
Maria Giulia Demarzo Italy	9	140 1.1×	95 1.0×	105 1.4×	3 0.1×	23 1.0×	22	281
Kathleen O. Stewart United States	7	160 1.2×	135 1.4×	94 1.2×	5 0.2×	35 1.6×	14	242
John S. Kane United Kingdom	11	121 0.9×	177 1.9×	126 1.7×	2 0.1×	15 0.7×	14	353
Krupa Krishnaprasad India	7	121 0.9×	89 0.9×	50 0.7×	5 0.2×	14 0.6×	31	180
Joana Roseira Portugal	8	92 0.7×	61 0.6×	52 0.7×	3 0.1×	18 0.8×	22	180

Countries citing papers authored by Daniel Ceballos

Since Specialization

Citations

This map shows the geographic impact of Daniel Ceballos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ceballos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ceballos more than expected).

Fields of papers citing papers by Daniel Ceballos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ceballos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ceballos. The network helps show where Daniel Ceballos may publish in the future.

Co-authorship network of co-authors of Daniel Ceballos

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ceballos. A scholar is included among the top collaborators of Daniel Ceballos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ceballos. Daniel Ceballos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crespo, Javier, Fernando Alberca, Federico Argüelles‐Arias, et al.. (2025). Digestive Disease in Individuals Living with Obesity: Beyond Weight Loss.. Revista Española de Enfermedades Digestivas. 1 indexed citations

González‐Lama, Yago, Elena Ricart, Daniel Carpio, et al.. (2024). Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus. BMJ Open Gastroenterology. 11(1). e001246–e001246.

Bastida, Guillermo, Daniel Carpio, Daniel Ceballos, et al.. (2024). Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations. Crohn s & Colitis 360. 6(4). otae055–otae055. 3 indexed citations

Bastida, Guillermo, Mariam Aguas, Manuel Barreiro‐de Acosta, et al.. (2023). The Risk of Developing Disabling Crohn’s Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making. Digestive Diseases. 41(6). 879–889. 3 indexed citations

Reinisch, Walter, Marjolijn Duijvestein, Daniel Ceballos, et al.. (2023). P546 Comparative efficacy and safety of upadacitinib versus ustekinumab as induction therapy in patients with moderately to severely active ulcerative colitis: A matching-adjusted indirect comparison. Journal of Crohn s and Colitis. 17(Supplement_1). i672–i673. 3 indexed citations

Ceballos, Daniel, Alejandro Hernández-Camba, & Laura Ramos. (2021). Diet and microbiome in the beginning of the sequence of gut inflammation. World Journal of Clinical Cases. 9(36). 11122–11147. 21 indexed citations

Marín‐Jiménez, Ignacio, Manuel Barreiro‐de Acosta, María Esteve, et al.. (2021). Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study. Gastroenterología y Hepatología. 45(3). 165–176. 4 indexed citations

Ceballos, Daniel. (2021). Predictors: How to Approach the Individualization of Treatment. Inflammatory Bowel Diseases. 27(11). 1876–1877. 1 indexed citations

Ramos, Laura, Alejandro Hernández-Camba, Marta Carrillo‐Palau, et al.. (2020). Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: what have we learned from our patients?. Revista Española de Enfermedades Digestivas. 112(8). 636–641. 1 indexed citations

10.

Echarri, Ana, Isabel Vera, C Aràjol, et al.. (2019). The Harvey–Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study. Telemedicine Journal and e-Health. 26(1). 78–86. 21 indexed citations

11.

Chaparro, María, José Luis Cabriada, María José Casanova, et al.. (2018). P423 Epidemiology, diagnostic work-up and pharmacological requirements of inflammatory bowel disease (IBD) in Spain: Results from the nationwide EpidemIBD study of GETECCU. Journal of Crohn s and Colitis. 12(supplement_1). S318–S319.

12.

Echarri, Ana, Isabel Vera, Jordi Guardiola, et al.. (2018). P339 Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study. Journal of Crohn s and Colitis. 12(supplement_1). S273–S273. 1 indexed citations

13.

Ramos, Laura, Alejandro Hernández-Camba, Marta Carrillo‐Palau, et al.. (2018). P779 Clinical outcome with biological therapy in ulcerative colitis: Real-world clinical setting from a multi-centre observational study. Journal of Crohn s and Colitis. 12(supplement_1). S504–S504. 1 indexed citations

14.

Saro, Cristina, Daniel Ceballos, Fernándo Muñoz, et al.. (2016). Clinical status, quality of life, and work productivity in Crohns disease patients after one year of treatment with adalimumab. Revista Española de Enfermedades Digestivas. 109(2). 122–129. 6 indexed citations

15.

Ceballos, Daniel, et al.. (2015). Perforaciones duodenales tras colangiopancreatografía retrógrada endoscópica. Cirugía Española. 93(6). 403–410. 6 indexed citations

16.

Saro, Cristina, Daniel Ceballos, Fernándo Muñoz, et al.. (2015). Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohnʼs Disease Patients. Inflammatory Bowel Diseases. 21(7). 1631–1640. 7 indexed citations

17.

Ceballos, Daniel, et al.. (2015). Duodenal Perforations After Endoscopic Retrograde Cholangiopancreatography. Cirugía Española (English Edition). 93(6). 403–410. 7 indexed citations

18.

Clavo, Bernardino, Daniel Ceballos, Gerardo Suárez, et al.. (2012). Long-Term Control of Refractory Hemorrhagic Radiation Proctitis With Ozone Therapy. Journal of Pain and Symptom Management. 46(1). 106–112. 19 indexed citations

19.

Hinojosa, Joaquín, Fernando Gomollón, Guillermo Bastida, et al.. (2007). Efficacy and safety of short‐term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open‐label, multicentre trial. Alimentary Pharmacology & Therapeutics. 25(4). 409–418. 79 indexed citations

20.

Gomollón, Fernando, Joaquín Hinojosa, Pilar Nos, et al.. (2007). Long-Term Results of Adalimumab Treatment in Subjects with Moderately to Severely Active Fistulizing Crohnʼs Disease Who Have Failed Response or Showed Intolerance to Infliximab. The American Journal of Gastroenterology. 102. S496–S496. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact